|
Munarriz D, Lopez-Godino O, Martinez-Cibrian N, Albiol N, Brillembourg H, Navarro-Velazquez S, Espanol-Rego M, Casanueva S, Garcia-Tomas L, Munoz-Sanchez G, Alserawan L, Benitez-Ribas D, Magnano L, Correa JG, Rivero A, Mozas P, Gine E, Rodriguez-Lobato LG, Martinez-Roca A, Montoro-Lorite M, Ayora P, Esteve J, Frutos L, Balague-Ponz O, Urbano-Ispizua A, Gonzalez-Navarro EA, Juan M, Delgado J, Ortiz-Maldonado V. Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report. Int J Mol Sci. 2025 Sep 23;26(19):9265. doi: 10.3390/ijms26199265. PubMed PMID: 41096533; PubMed Central PMCID: PMC12524146.
AÑO: 2025; IF: 4.9
|
41096533
|
Jimenez-Vicente C, Beneit P, Cano-Ferri I, Merchan B, Arnan M, Guinon AG, Martinez-Bilbao C, Alfonso A, Martinez-Sanchez P, Alonso-Dominguez JM, Lopez-Godino O, Castano-Diez S, Zugasti I, Esteve J, Diaz-Beya M, de la Fuente A. Enasidenib as treatment for AML with IDH2 mutation: multicenter real-life study of the early-access program in Spain. Ann Hematol. 2025 Sep;104(9):4863-4871. doi: 10.1007/s00277-025-06464-1. Epub 2025 Jul 12. PubMed PMID: 40650712; PubMed Central PMCID: PMC12552362.
AÑO: 2025; IF: 2.4
|
|
Mingot-Castellano ME, Reguera-Ortega JL, Zafra Torres D, Hernani R, Lopez-Godino O, Guerreiro M, Herrero B, Lopez-Corral L, Luna A, Gonzalez-Pinedo L, Chinea-Rodriguez A, Africa-Martin A, Bailen R, Martinez-Cibrian N, Balsalobre P, Filaferro S, Alonso-Saladrigues A, Barba P, Perez-Martinez A, Calbacho M, Perez-Simon JA, Sanchez-Pina JM, On Behalf Of The Spanish Group Of Hematopoietic Transplant And Cell Therapy Geth-Tc. Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients. J Clin Med. 2024 Aug 28;13(17):5117. doi: 10.3390/jcm13175117. PubMed PMID: 39274330; PubMed Central PMCID: PMC11396136.
AÑO: 2024; IF: 2.9
|
|
Fonseca-Santos M, Bailen R, Lopez-Godino O, Herruzo-Delgado B, Bermudez MA, Garcia-Cadenas I, Huguet-Mas M, Ferra-Coll C, Esquirol A, Cortes-Rodriguez M, Yanez-Sansegundo L, Pascual-Cascon MJ, Heras I, Kwon M, Lopez-Corral L; Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular. Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC. Transplantation. 2024 Oct 1;108(10):2134-2143. doi: 10.1097/TP.0000000000005034. Epub 2024 Sep 24. PubMed PMID: 38685204.
AÑO: 2024; IF: 5.0
|
|
Mora E, Montoro J, Balaguer A, Rovira M, Cabrero M, Heras I, Ribera JM, Antelo G, Martin AA, Lopez Godino O, Torrent A, Villalba M, Chorao P, Sanz MA, Sanz J; Grupo Espanol de Trasplante Hematopoyetico (GETH). Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia. Bone Marrow Transplant. 2024 Aug;59(8):1137-1145. doi: 10.1038/s41409-024-02298-z. Epub 2024 May 16. PubMed PMID: 38755458.
AÑO: 2024; IF: 5.2
|